Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0367419970400060857
Journal of Korean Pediatric Society
1997 Volume.40 No. 6 p.857 ~ p.861
A Report of Familial Dilated Cardiomyopathy
±èÀÌ°æ
ÃÖÁ¤¿¬/³ëÁ¤ÀÏ À±¿ë¼ö/±èÈ£¼º/À̸íÇö/±èÀαÔ
Abstract
Two families of dilated cardiomyopathy are reported. In the first family, two sons were affected. The elder child presented with congestive symptoms at the age of 5months and was diagnosed cardiomyopathy. The etiology of cardiomyopathy was
thought
to be
idiopathic until his younger brother presented with near collapse at the age of 5 days and was diagnosed to have the same dilated cardiomyopathy. In both patients, total carnitine was slightly low and esterified form was not measured. Other
metabolic
screening, such as amino acid level, ammonia, and lactate level was within normal limit. The parents are unrelated and there is no other person in their family who have dilated cardiomyopathy. Both patients are on carnitine and anticongestive
measure,
but no significant changes in shortening fraction and left ventricular dimensions have been observed.
In the second family, two daughters were affected. The first pregnancy of unrelated couple ended in spontaneous abortion at a gestational age of 8 months. The second pregnancy resulted in a normal girl who is well and currently 9 years old. The
third
pregnancy produced a normal looking girl, but died of dilated cardiomyopathy as a neonate. The fourth pregnancy (propositus) was screened for fetal heart, which showed poorly contracting dilated both ventricles. The girl was delivered by section
at
a
gestational period of 39 weeks. She also presented with congestive symptoms as a neonate and laboratory test showed that total carnitine was slightly low and esterified form was normal. Other metabolic screening was negative. She was treated with
digoxin, diuretics, vasodilators, and carnitine, but has not shown any changes in symptoms or echocardiographic findings.
As far as we know, this is the first report of familial cardiomyopathy in Korea. In order to provide a better care to this rare disease, genetic and metabolic consultation as well as special laboratory facility should be readily available in
Korea.
KEYWORD
FullTexts / Linksout information
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø